Covidien (COV) Tops Q4 EPS by 3c, Reaffirms Guidance
Tweet
Share
E-mailGet Alerts COV Hot Sheet
Price: $106.71 --0%
Financial Fact:
Restructuring charges, net: -2M
Today's EPS Names:
LGCY, UXIN, SCHL, More
Financial Fact:
Restructuring charges, net: -2M
Today's EPS Names:
LGCY, UXIN, SCHL, More
Join SI Premium – FREE
Covidien (NYSE: COV) reported Q4 adjusted EPS of $1.08, $0.03 better than the analyst estimate of $1.05. Revenue for the quarter came in at $3.08 billion versus the consensus estimate of $3.03 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Covalon Reports Encouraging Findings From Real World Evidence Analysis Comparing Collagen Dressings
- Costco (COST) Tops Q4 EPS by 20c
- Covalon to Present at the 2026 Annual Smallcap Discoveries Conference After Reporting Revenue Growth of 20% and Gross Margin of 67%
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
